Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Duolingo, Inc. (NASDAQ:DUOL) fell sharply during Thursday's session after the company reported first quarter financial results.Duolingo reported quarterly earnings of 57 cents per share whic
LifeMD, Inc. (NASDAQ:LFMD) Q1 2024 Earnings Call Transcript
LifeMD Price Target Raised to $15.00/Share From $13.00 by Cantor Fitzgerald
LifeMD Price Target Raised to $15.00/Share From $13.00 by Cantor Fitzgerald
LifeMD Is Maintained at Overweight by Cantor Fitzgerald
LifeMD Is Maintained at Overweight by Cantor Fitzgerald
Express News | Cantor Fitzgerald Maintains Overweight on LifeMD, Raises Price Target to $15
LifeMD Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 53.06% Cantor Fitzgerald $13 → $15 Maintains Overweight 04/23/2024 42.86% BTIG $13 → $14 Mainta
Buy Rating Affirmed for LifeMD on Strong Performance and Strategic Growth Initiatives
Express News | LifeMD Inc : Craig-Hallum Raises Target Price to $16 From $15
Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD), NeuroPace (NPCE) and Dynavax (DVAX)
Q1 2024 LifeMD Inc Earnings Call
Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Other Big Stocks Moving Lower
U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Thursday.Shares of Exact Sciences Corporation (NASDAQ:EXAS) fell sharply in today's pre-market trading aft
Express News | LifeMD Shares Down 7.5% Premarket After Wider Q1 Loss
LifeMD Inc (LFMD) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and Optimistic ...
LifeMD, Inc. (LFMD) Q1 2024 Earnings Call Transcript
LifeMD, Inc. (LFMD) Q1 2024 Earnings Call Transcript
Express News | LifeMD Shares Are Trading Lower Following Q1 Earnings
LifeMD Shares Are Trading Lower Following Q1 Earnings.
LifeMD Shares Are Trading Lower Following Q1 Earnings.
LifeMD Expects Q2 Revenue Of $48M-$50M, Est $47.141M
LifeMD Expects Q2 Revenue Of $48M-$50M, Est $47.141M
LifeMD Raises FY24 Revenue Guidance To At Least $205M, Up From Prior Guidance Of At Least $200M (Est $201.378M)
LifeMD Raises FY24 Revenue Guidance To At Least $205M, Up From Prior Guidance Of At Least $200M (Est $201.378M)
LifeMD Q1 2024 Adj EPS $0.01 Beats $(0.15) Estimate, Sales $44.144M Beat $42.540M Estimate
LifeMD (NASDAQ:LFMD) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.15) by 106.67 percent. This is a 83.33 percent decrease over earnings of $0.06 per
10-Q: Quarterly report
No Data